- Study finds most smokers lack knowledge on ways to quit smoking
- Harvard School survey asserts NRT ineffective in spite of body of evidence to the contrary
- Report: Nicotine replacement product sales to reach $6.2 billion worldwide by 2018
- GSK Consumer Healthcare applauds FDA's workshop on NRT products
- Green Smoke e-cigarettes launches a new and reusable carrying case
BELLEFONTAINE, Ohio — Arco Health, Inc., makers of Diet-Burst gum, announced last week new packaging designs for its dietary supplement gum, as well as new nicotine replacement products available in July.
The NicoBurst line of products are designed to help smokers end their dependency on smoking traditional cigarettes. The NicoBurst disposable e-cigarette has a traditional tobacoo flavor and provides the same nicotine experience to satisfy a smoker's cravings. The cigarette replacement product comes after two years of research and development.
In addition to NicoBurst e-cigarettes, Arco Health will be offering NicoBurst gum and lozenges. NicoBurst chewing gum will be available in 2 mg and 4 mg of nicotine, and NicoBurst lozenges in 2 mg and 4 mg of nicotine.
The company also announced new packaging for its already available Diet-Burst gum, a patented nutraceutical containing Slendesta, an over-the-counter dietary supplement. Diet-Burst gum can be used as a replacement to cigarettes for those smokers who use cigarettes as a means to control their weight. Diet-Burst gum is now available in a two-piece blister pack and an eight-count point-of-purchase display box for retail trade.
NicoBurst electronic cigarettes and DietBurst gum are not smoking cessation products and have not been evaluated by the Food and Drug Administration, nor are they intended to diagnose, treat, cure or prevent any disease. NicoBurst nicotine gum and nicotine lozenges have been evaluated by the Food and Drug Administration and have been approved by the FDA as Nicotine Replacement Therapy products.
Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.